Head-to-head · Cost-Efficiency Index
MDExam vs Society of You
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
MDExam
Cost-first shoppers who want a lower injectable-semaglutide starting price than the site's own headline claim advertises.
Visit MDExamSociety of You
Shoppers open to completing an eligibility quiz before seeing any price, since none is public.
Visit Society of YouThe verdict
MDExam and Society of You tie on the Cost-Efficiency Index at 49/100, so neither wins outright on the numbers. For most shoppers we'd start with MDExam (ranked #423, a hair above #425) — Cost-first shoppers who want a lower injectable-semaglutide starting price than the site's own headline claim advertises. But Society of You is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs MDExam.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | MDExam | Society of You |
|---|---|---|
| Cost-Efficiency Index | 49/100 | 49/100 |
| Semaglutide / mo | $192/mo (compounded) | Not disclosed |
| Tirzepatide / mo | $258/mo (compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $2,304 | — |
| Tirzepatide / yr (modeled) | $3,096 | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #423 | #425 |
MDExam
49/100Where the value is
- Injectable semaglutide at $192/mo undercuts the company's own advertised '$225 as low as' floor
- Accepts insurance for eligible patients in addition to cash-pay options
- 100% refund offered if a patient doesn't qualify after evaluation
The tradeoffs
- The site's own headline claim ('priced as low as $225/month') doesn't match either actual product price — tirzepatide at $258/mo is more expensive than the claimed floor, which should make a shopper distrust the headline number generally
- No specific dose is disclosed for either the $192 or $258 figure, making it impossible to know what's actually being compared
Society of You
49/100Where the value is
- Offers both compounded and branded GLP-1 options (Ozempic/Wegovy/Mounjaro) plus microdosing
- Part of a broader longevity/performance platform with sexual health and skin/hair verticals
- Mobile apps available on iOS and Android
The tradeoffs
- No public pricing page -- the linked /pricing URL 404s, so cost is fully gated behind signup
- No named medical director found in reachable content
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.